Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 2002 Apr;48:695–697.

Use of warfarin during pregnancy.

Shirin Abadi 1, Adrienne Einarson 1, Gideon Koren 1
PMCID: PMC2214036  PMID: 12046363

Abstract

QUESTION: One of my patients, who has been taking warfarin for some time for treatment and prophylaxis of deep vein thrombosis, became pregnant due to failed contraception. I am unsure how to counsel her. Is there evidence that warfarin use during pregnancy is associated with fetal risk? ANSWER: If possible, warfarin therapy should be avoided during pregnancy. If warfarin therapy is essential, it should be avoided at least during the first trimester (because of teratogenicity) and from about 2 to 4 weeks before delivery to reduce risk of hemorrhagic complications. Unfractionated heparin or low molecular weight heparin could be substituted when appropriate because these agents do not cross the placenta and are considered the anticoagulant drugs of choice during pregnancy.

Full Text

The Full Text of this article is available as a PDF (109.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayhan A., Yapar E. G., Yüce K., Kişnişci H. A., Nazli N., Ozmen F. Pregnancy and its complications after cardiac valve replacement. Int J Gynaecol Obstet. 1991 Jun;35(2):117–122. doi: 10.1016/0020-7292(91)90813-k. [DOI] [PubMed] [Google Scholar]
  2. Born D., Martinez E. E., Almeida P. A., Santos D. V., Carvalho A. C., Moron A. F., Miyasaki C. H., Moraes S. D., Ambrose J. A. Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate. Am Heart J. 1992 Aug;124(2):413–417. doi: 10.1016/0002-8703(92)90606-v. [DOI] [PubMed] [Google Scholar]
  3. Chong M. K., Harvey D., de Swiet M. Follow-up study of children whose mothers were treated with warfarin during pregnancy. Br J Obstet Gynaecol. 1984 Nov;91(11):1070–1073. doi: 10.1111/j.1471-0528.1984.tb15077.x. [DOI] [PubMed] [Google Scholar]
  4. Hall B. D. Warfarin embryopathy and urinary tract anomalies: possible new association. Am J Med Genet. 1989 Oct;34(2):292–293. doi: 10.1002/ajmg.1320340234. [DOI] [PubMed] [Google Scholar]
  5. Hall J. G., Pauli R. M., Wilson K. M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980 Jan;68(1):122–140. doi: 10.1016/0002-9343(80)90181-3. [DOI] [PubMed] [Google Scholar]
  6. Holzgreve W., Carey J. C., Hall B. D. Warfarin-induced fetal abnormalities. Lancet. 1976 Oct 23;2(7991):914–915. doi: 10.1016/s0140-6736(76)90587-0. [DOI] [PubMed] [Google Scholar]
  7. Howe A. M., Webster W. S. The warfarin embryopathy: a rat model showing maxillonasal hypoplasia and other skeletal disturbances. Teratology. 1992 Oct;46(4):379–390. doi: 10.1002/tera.1420460408. [DOI] [PubMed] [Google Scholar]
  8. Lee P. K., Wang R. Y., Chow J. S., Cheung K. L., Wong V. C., Chan T. K. Combined use of warfarin and adjusted subcutaneous heparin during pregnancy in patients with an artificial heart valve. J Am Coll Cardiol. 1986 Jul;8(1):221–224. doi: 10.1016/s0735-1097(86)80116-4. [DOI] [PubMed] [Google Scholar]
  9. Oakley C. Pregnancy in patients with prosthetic heart valves. Br Med J (Clin Res Ed) 1983 May 28;286(6379):1680–1682. doi: 10.1136/bmj.286.6379.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pillans P. I., Coetzee E. J. Anticoagulation during pregnancy. S Afr Med J. 1986 Apr 12;69(8):469–469. [PubMed] [Google Scholar]
  11. Sareli P., England M. J., Berk M. R., Marcus R. H., Epstein M., Driscoll J., Meyer T., McIntyre J., van Gelderen C. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol. 1989 Jun 15;63(20):1462–1465. doi: 10.1016/0002-9149(89)90008-8. [DOI] [PubMed] [Google Scholar]
  12. Sbarouni E., Oakley C. M. Outcome of pregnancy in women with valve prostheses. Br Heart J. 1994 Feb;71(2):196–201. doi: 10.1136/hrt.71.2.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Schneider D. M., von Tempelhoff G. F., Heilmann L. Retrospective evaluation of the safety and efficacy of low-molecular-weight heparin as thromboprophylaxis during pregnancy. Am J Obstet Gynecol. 1997 Dec;177(6):1567–1568. doi: 10.1016/s0002-9378(97)70134-0. [DOI] [PubMed] [Google Scholar]
  14. Vitale N., De Feo M., De Santo L. S., Pollice A., Tedesco N., Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999 May;33(6):1637–1641. doi: 10.1016/s0735-1097(99)00044-3. [DOI] [PubMed] [Google Scholar]
  15. Vitali E., Donatelli F., Quaini E., Groppelli G., Pellegrini A. Pregnancy in patients with mechanical prosthetic heart valves. Our experience regarding 98 pregnancies in 57 patients. J Cardiovasc Surg (Torino) 1986 Mar-Apr;27(2):221–227. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES